Jana, a 4-year-old girl from a modest family, is battling spinal muscular atrophy (SMA). She urgently needs 28 doses of Risdiplam, a life-saving medication that costs $2,000 per dose. The total cost for her treatment is $56,000. Her father works as a laborer, and her mother stays home to care for her, but the family cannot afford this critical treatment independently. Jana's condition is progressing, and timely treatment is essential for her survival and well-being.
Jana, a 4-year-old girl, is suffering from spinal muscular atrophy (SMA), a serious and progressive medical condition that weakens the muscles and affects mobility. Without treatment, SMA can severely impact a child's ability to move, breathe, and perform basic functions. To manage this condition, Jana needs a life-saving medication called Risdiplam. She requires a total of 28 doses of Risdiplam, with each dose costing $2,000, bringing the total treatment cost to $56,000.
This project aims to solve the problem by funding the necessary treatment for Jana. The primary goal is to cover the cost of 28 doses of Risdiplam, which is the life-saving medication Jana needs to manage her spinal muscular atrophy (SMA). By securing the required $56,000, the project will: Ensure Jana receives the full course of treatment, Provide her family with hope and Improve her chances for long-term survival.
Executing this project will provide Jana, a 4-year-old with spinal muscular atrophy (SMA), the life-saving treatment she urgently needs. By receiving 28 doses of Risdiplam, Jana's condition can be stabilized, improving her mobility, increasing her lifespan, and reducing severe complications. This project will also relieve her family's financial burden, raise awareness for SMA, and potentially improve access to treatment for other children with similar needs, creating a lasting impact.
